MannKind’s Long, Winding Development Road Ends In Approval Of Afrezza Inhaled Insulin
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm now faces the commercial gauntlet of establishing an inhaled insulin in the crowded diabetes market.